First Trust Direct Indexing’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40,755
| Closed | -$580K | – | 815 |
|
|
2024
Q3 | $580K | Sell |
40,755
-4,212
| -9% | -$59.9K | 0.03% | 500 |
|
|
2024
Q2 | $582K | Sell |
44,967
-8,068
| -15% | -$104K | 0.04% | 459 |
|
|
2024
Q1 | $737K | Sell |
53,035
-12,691
| -19% | -$176K | 0.05% | 367 |
|
|
2023
Q4 | $938K | Sell |
65,726
-5,332
| -8% | -$76.1K | 0.08% | 276 |
|
|
2023
Q3 | $1.1M | Buy |
71,058
+12,943
| +22% | +$200K | 0.13% | 178 |
|
|
2023
Q2 | $913K | Sell |
58,115
-2,729
| -4% | -$42.9K | 0.1% | 236 |
|
|
2023
Q1 | $1M | Buy |
60,844
+462
| +0.8% | +$7.61K | 0.12% | 209 |
|
|
2022
Q4 | $942K | Sell |
60,382
-3,097
| -5% | -$48.3K | 0.12% | 217 |
|
|
2022
Q3 | $823K | Buy |
63,479
+24,560
| +63% | +$318K | 0.12% | 226 |
|
|
2022
Q2 | $546K | Buy |
38,919
+11,415
| +42% | +$160K | 0.08% | 333 |
|
|
2022
Q1 | $394K | Buy |
+27,504
| New | +$394K | 0.05% | 423 |
|
|
2021
Q4 | – | Sell |
-21,842
| Closed | -$358K | – | 687 |
|
|
2021
Q3 | $358K | Buy |
21,842
+768
| +4% | +$12.6K | 0.05% | 426 |
|
|
2021
Q2 | $355K | Buy |
21,074
+10,696
| +103% | +$180K | 0.05% | 422 |
|
|
2021
Q1 | $190K | Buy |
10,378
+1,306
| +14% | +$23.9K | 0.05% | 379 |
|
|
2020
Q4 | $165K | Buy |
+9,072
| New | +$165K | 0.04% | 387 |
|